Histopathologic parameters of prognosis in cervical cancer - a review

被引:103
|
作者
Singh, N [1 ]
Arif, S [1 ]
机构
[1] St Bartholomews Hosp, Dept Histopathol, London EC1A 7BE, England
关键词
cervical cancer; depth; grade tumor type; grading systems; histopathology; margins; prognosis; stage; vascular invasion; volume;
D O I
10.1111/j.1048-891X.2004.014504.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apart from clinical stage and lymph node status, acknowledged to be among the most powerful predictors of outcome in cervical cancer, the determination of prognosis and thereby the need for adjuvant therapy in surgically treated patients currently relies on a variety of histopathologic factors. The role of many of these is controversial. This may be because histopathology is genuinely lacking in sensitivity for predicting tumor behavior in vivo. There is, however, wide variation in histopathologic definitions and criteria. This is probably the major reason for both the lack of reproducibility in the reporting of certain factors and in their diminished value in predicting behavior. Tumor type, grade, vascular invasion, pattern of invasion, and depth are all extremely important prognostic indicators when used individually or as a part of a scoring system.
引用
收藏
页码:741 / 750
页数:10
相关论文
共 50 条
  • [31] URINARY NEOPTERIN IN PROGNOSIS OF CERVICAL-CANCER
    REIBNEGGER, G
    BICHLER, A
    FUCHS, D
    FUITH, L
    HAUSEN, A
    HETZEL, H
    WERNER, ER
    WACHTER, H
    TUMOUR BIOLOGY, 1985, 6 (04): : 436 - 436
  • [32] The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy
    Pedraza, Sara
    Seiffert, Alexander P.
    Sarandeses, Pilar
    Munoz-Lopez, Beatriz
    Gomez, Enrique J.
    Sanchez-Gonzalez, Patricia
    Perez-Regadera, Jose F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (09) : 792 - 801
  • [33] THE SIGNIFICANCE OF HPV GENOTYPE IN THE PROGNOSIS OF CERVICAL CANCER
    Kim, Y.
    Park, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 693 - 693
  • [34] Novel predictive biomarkers for cervical cancer prognosis
    Moreno-Acosta, Pablo
    Carrillo, Schyrly
    Gamboa, Oscar
    Romero-Rojas, Alfredo
    Acosta, Jinneth
    Molano, Monica
    Balart-Serra, Joseph
    Cotes, Martha
    Rancoule, Chloe
    Magne, Nicolas
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (06) : 792 - 796
  • [35] Clinicopathological factors influencing the prognosis of cervical cancer
    Gai, Junfeng
    Wang, Xiaoyan
    Meng, Yun
    Xu, Zengling
    Kou, Mingjie
    Liu, Yongli
    JOURNAL OF BUON, 2019, 24 (01): : 291 - 295
  • [36] A MicroRNA Expression Signature for Cervical Cancer Prognosis
    Hu, Xiaoxia
    Schwarz, Julie K.
    Lewis, James S., Jr.
    Huettner, Phyllis C.
    Rader, Janet S.
    Deasy, Joseph O.
    Grigsby, Perry W.
    Wang, Xiaowei
    CANCER RESEARCH, 2010, 70 (04) : 1441 - 1448
  • [37] PAPILLOMAVIRUS DNA AND PROGNOSIS IN CERVICAL-CANCER
    ROSE, BR
    THOMPSON, CH
    COSSART, YE
    ELLIOT, PE
    TATTERSALL, MHN
    LANCET, 1991, 337 (8739): : 489 - 489
  • [38] The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy
    Sara Pedraza
    Alexander P. Seiffert
    Pilar Sarandeses
    Beatriz Muñoz-Lopez
    Enrique J. Gómez
    Patricia Sánchez-González
    José F. Pérez-Regadera
    Strahlentherapie und Onkologie, 2022, 198 : 792 - 801
  • [39] Influence of Nanog expression on prognosis of cervical cancer
    Kim, B.
    Conway, C.
    Kris, Y.
    Hewitt, S.
    Cho, H.
    Kim, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S62 - S62
  • [40] Tissue parameters of prognosis in breast cancer
    Pouillart, P
    Dieras, V
    BULLETIN DU CANCER, 1996, 83 (12) : 1029 - 1030